-
Better Buy: Amgen Inc. vs. Biogen
Post on 12/12/16
-
The 3 Best Biotech Stocks for 2017
Post on 12/9/16
-
Pfizer (PFE) Management Presents at Citi Global Healthcare Conference (Transcript)
Post on 12/9/16
-
Better Buy: Johnson & Johnson vs. Pfizer Inc.
Post on 12/9/16
-
Early Stage Digital Health Companies In Philadelphia Get Boost With $6 Million Funding Initiative
Post on 12/8/16
-
PANTHERx Specialty Pharmacy Ranks #1 in Patient Satisfaction
Post on 12/8/16
-
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
Post on 12/8/16
-
Why You Should (and Shouldn't) Buy Celldex Therapeutics, Inc.
Post on 12/8/16
-
Why Celldex Rallied 22% In November
Post on 12/8/16
-
Better Buy: Amgen Inc. vs. Pfizer
Post on 12/8/16
-
Is Pfizer's New PD-L1 Drug a Game-Changer?
Post on 12/8/16
-
Better Buy: Johnson & Johnson vs. Eli Lilly
Post on 12/8/16
-
Zoetis Announces Authorization of $1.5 Billion Share Repurchase Program
Post on 12/6/16
-
J&J Target Offers Over 20% Upside
Post on 12/6/16
-
Novartis Makes Its Case For Driving A CAR Into The Real World
Post on 12/6/16
-
Biotech's Dumbest CEO Moves in 2016
Post on 12/6/16
-
Why PTC Therapeutics, Inc. Stock Rose 75.4% in November
Post on 12/6/16
-
Why Celgene Shares Jumped 13.9% In November
Post on 12/6/16
-
Read This Before You Buy Biotech Stocks
Post on 12/6/16
-
Ogilvy CommonHealth Worldwide Wins Silver At 2016 Clio Health Awards
Post on 12/6/16
-
Forget Pfizer: Here Are 3 Better Dividend Stocks
Post on 12/5/16
-
Does Pfizer Pass Warren Buffett’s Test?
Post on 12/5/16
-
This Trump Appointment Likely Spells Imminent Doom for Obamacare
Post on 12/5/16
-
Retro Fitness Expands Florida Footprint through Franchising
Post on 12/4/16
-
The Wistar Institute Awarded Nearly $9 Million to Advance Synthetic DNA Antibody-Based Therapy to Protect Against Zika Virus
Post on 12/1/16
Philadelphia
